ultimovacs.com

Ultimovacs

Enabling the immune system to fight cancer. Ultimovacs is a small pharmaceutical company developing novel immunotherapy against cancer. Our leading product is UV1, a therapeutic cancer vaccine (TCV) directed against human telomerase (hTERT). The vaccine is a result of many years of pre-clinical and clinical research at the Norwegian Radium Hospital. UV1 is a synthetic peptide vaccine. The major owners of Ultimovacs are Gjelsten Holding. The Norwegian Radium Hospital Research Foundation. 47 909 71 226.

http://www.ultimovacs.com/

OVERVIEW OF ultimovacs.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR ULTIMOVACS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 7 reviews

5 star

4

4 star

1

3 star

1

2 star

0

1 star

1

Hey there! Start your review of ultimovacs.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

2.6 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128

CONTACTS AT ULTIMOVACS.COM

Ultimovacs AS

Audun Tornes

Post●●●●1061

O●O , 0316

NO

47.9●●●●0951

zz●●●●●●●●●●@spamprotection.email

View this contact

Ultimovacs AS

Audun Tornes

Post●●●●1061

O●O , 0316

NO

47.9●●●●0951

47.2●●●●0081

8h●●●●●●●●●●@spamprotection.email

View this contact

DOMENESHOP AS

Domeneshop Hostmaster

Christia●●●●●●●● gate 16

O●o , 0186

NO

47.2●●●●3333

47.2●●●●3334

ho●●●●●●●●@domeneshop.no

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2010 December 08
UPDATED: 2014 July 21
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

13

YEARS
5

MONTHS
8

DAYS

NAME SERVERS

1: ns1.hyp.net
2: ns2.hyp.net
3: ns3.hyp.net

REGISTRAR

DOMENESHOP AS

WHOIS : whois.domainnameshop.com

REFERRED : http://www.domainnameshop.com

CONTENT

PAGES IN
THIS WEBSITE

6

SSL

EXTERNAL LINKS

4

SITE IP

194.63.248.86

LOAD TIME

2.591 sec

SCORE

6.2

PAGE TITLE

Ultimovacs | ultimovacs.com Reviews

<META> DESCRIPTION

Enabling the immune system to fight cancer. Ultimovacs is a small pharmaceutical company developing novel immunotherapy against cancer. Our leading product is UV1, a therapeutic cancer vaccine (TCV) directed against human telomerase (hTERT). The vaccine is a result of many years of pre-clinical and clinical research at the Norwegian Radium Hospital. UV1 is a synthetic peptide vaccine. The major owners of Ultimovacs are Gjelsten Holding. The Norwegian Radium Hospital Research Foundation. 47 909 71 226.

<META> KEYWORDS

1 menu

2 about ultimovacs

3 management

4 board of directors

5 technology

6 study pipeline

7 owners

8 for patients

9 funding and competence

10 inven2

CONTENT

Page content here

KEYWORDS ON PAGE

menu,about ultimovacs,management,board of directors,technology,study pipeline,owners,for patients,funding and competence,inven2,canica as,sundt as,chief executive officer,oeyvind arnesen@ultimovacs com,download vcard,audun tornes,chief operating officer

SERVER

Apache/2.2.16

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Ultimovacs | ultimovacs.com Reviews

https://ultimovacs.com

Enabling the immune system to fight cancer. Ultimovacs is a small pharmaceutical company developing novel immunotherapy against cancer. Our leading product is UV1, a therapeutic cancer vaccine (TCV) directed against human telomerase (hTERT). The vaccine is a result of many years of pre-clinical and clinical research at the Norwegian Radium Hospital. UV1 is a synthetic peptide vaccine. The major owners of Ultimovacs are Gjelsten Holding. The Norwegian Radium Hospital Research Foundation. 47 909 71 226.

INTERNAL PAGES

ultimovacs.com

1

For Patients | Ultimovacs

http://ultimovacs.com/for-patients

Ultimovacs AS is developing a new type of cancer treatment. We are currently documenting the safety and efficacy. We do not yet have enough data regarding safety or efficacy to use the treatment outside of our clinical trial program. If you are a cancer patient and wish to participate in a clinical trial, you should discuss this with the physician responsible for your treatment. 47 450 22 471.

2

Team | Ultimovacs

http://ultimovacs.com/home/management

Øyvind K. Arnesen. 47 909 71 226. MD with 10 years of clinical experience and 10 years of experience from pharma industry with positions as Medical Director Norway (Bristol-Myers Squibb), Medical Director and Head of Clinical Operations Nordic countries in Boehringer Ingelheim. Member of The National Commission for the Investigation of Research Misconduct in Norway. Board member of the Norwegian Pharmaceutical Industry Association. 10 years’ experience within R&D from academia and biotech industry within...

3

Board of Directors | Ultimovacs

http://ultimovacs.com/home/board-of-directors

47 450 22 471.

4

Owners | Ultimovacs

http://ultimovacs.com/owners

Inven2 is the next-generation innovation company, established to maintain and develop Norwegian innovations. Inven2 builds bridges between excellent research and the next generation technology based industry. Inven2 is the largest contributor in Norway within the field of commercialization of research, owned by the University of Oslo and Oslo University Hospital, Norway’s largest and leading university and hospital representing pioneering research. Sundt AS is a privately owned investment company.

5

About Ultimovacs | Ultimovacs

http://ultimovacs.com/home/about-ultimovacs

Ultimovacs is a small pharmaceutical company developing novel immunotherapy against cancer. Our leading product is UV1, a therapeutic cancer vaccine (TCV) directed against human telomerase (hTERT). The vaccine is a result of many years of pre-clinical and clinical research at the Norwegian Radium Hospital. UV1 is a synthetic peptide vaccine. The company is currently performing three clinical trials with UV1. The major owners of Ultimovacs are Gjelsten Holding. 47 450 22 471.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

internationalcancercluster.org

Presenting Companies - International Cancer Cluster Showcase 2016

http://www.internationalcancercluster.org/presenting-companies.html

International Cancer Cluster Showcase 2016. The 2016 presenting companies. Click on the company logo or name for their presentation. Siamab Therapeutics, Inc. T 1 617 500-3455. T 32 (0) 477566102. T 1 617 755-8679. Vice President, Buss. Dev. Nced medicinal chemistry groups in Canada. Our mission is to rapidly translate highly innovative and commercially promising projects from IRIC/UdeM/collaborating centres in . To h . Et with the best targeted partners for development and financing. . Ovensa Inc&#46...

gjelsten.no

Gjelsten Holding AS › Selskaper › Ultimovacs

http://www.gjelsten.no/companies/ultimovacs.html

UTVIKLING AV BANEBRYTENDE KREFTVAKSINE BASERT PÅ LEDENDE, NORSK FORSKNING. Vaksinen som utvikles av Ultimovacs er tiltenkt behandling av de fleste krefttyper. Det internasjonale potensialet for denne typen kreftvaksine er betydelig. Gjelsten Holding AS eier 39% av Ultimovacs. Les mer om Ultimovacs på www.ultimovacs.com. Telf: 22 01 05 40. Fax: 22 01 05 41.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

4

OTHER SITES

ultimotv.it

www.ultimotv.it

ultimouomo.com

L'Ultimo Uomo | Sport & Cultura

14 ago 2015 - Alfredo Giacobbe, Cesare Alemanni e Mauro F. Giorgio. 13 ago 2015 - Daniele Manusia. 5 predestinati di Premier League. 12 ago 2015 - Lorenzo De Alexandris. 10 ago 2015 - Alfredo Giacobbe. 10 ago 2015 - Antonio Moschella. I tre atti di Sabatini. 7 ago 2015 - Francesco Costa. Viva la Ligue 1! 7 ago 2015 - Daniele Manusia, Dario Saltari e Francesco Lisanti. 6 ago 2015 - Alfredo Giacobbe. Viva la Premier League! 6 ago 2015 - Redazione. 5 ago 2015 - Fabrizio Gabrielli. Lavorare con le onde.

ultimous.com

ULTIMOUS Business Solutions

ULTIMOUS - Strength in Systems. We specialize in: Accounting, bookkeeping, procurement, information systems design and implementations, DCAA/FAR compliance, forensic analysis and remediation plans, internal controls/policy and procedure documentation, training and employee development, outsourcing/change management, government contracting, Deltek Costpoint, GCS, JAMIS, Oracle E-Business Suite R12.1, QuickBooks, PROCAS, and much much more!

ultimous.skyrock.com

Blog de Ultimous - Blog de Ultimous - Skyrock.com

Mot de passe :. J'ai oublié mon mot de passe. Mise à jour :. Abonne-toi à mon blog! Notorious B.I.G (Biggie Smalls) Bullshit And Party (Original Video 1993). Ajouter cette vidéo à mon blog. N'oublie pas que les propos injurieux, racistes, etc. sont interdits par les conditions générales d'utilisation de Skyrock et que tu peux être identifié par ton adresse internet (67.219.144.114) si quelqu'un porte plainte. Ou poster avec :. Posté le jeudi 21 février 2013 11:20. Ajouter cette vidéo à mon blog. Posté le...

ultimoutopico.blogspot.com

ultimoutopico .

Subscribe to: Posts (Atom). View my complete profile. Simple theme. Powered by Blogger.

ultimovacs.com

Ultimovacs

Enabling the immune system to fight cancer. Ultimovacs is a small pharmaceutical company developing novel immunotherapy against cancer. Our leading product is UV1, a therapeutic cancer vaccine (TCV) directed against human telomerase (hTERT). The vaccine is a result of many years of pre-clinical and clinical research at the Norwegian Radium Hospital. UV1 is a synthetic peptide vaccine. The major owners of Ultimovacs are Gjelsten Holding. The Norwegian Radium Hospital Research Foundation. 47 909 71 226.

ultimovagonteatro.blogspot.com

Ultimo Vagón

Reestreno SABADO 3 de SEPTIEMBRE a las 23hs en Boedo XXI. En un mundo sordo es probable que el olvido sea la buena memoria". Por un instante estos personajes, reflejos del reflejo de algun otro,intentaràn transitar el espacio de sombra que proyecta el mundo de los vìnculos que construimos. Ese paisaje del que nadie quiere dar cuenta, esa isla desconocida que describiò Saramago y antes algun otro.Cegados por el efecto de la inspiraciòn, esa gota que siempre dejamos. Escrita y dirigida por Ulises Martino.

ultimovalue.com

TV Mounts | Monitor Mounts and Electronics - UltimoValue.com

Bull; My Account. Bull; My Wishlist. Bull; My Cart. Are you an new Ultimo Customer? Create your own account and. 9am - 5pm PST. Free Shipping on orders over 50$. TV and Display Mounts. TV Ceiling Mounts / Under Cabinet Mounts. Monitor Mounts / Stands. Laptop Power Banks and Chargers. Battery Chargers and Cases. DVD/Component Wall Mount Shelf and TV Stands. Home Theater Speaker Systems. Speaker Mounts and Stands. Monitor Mounts / Monitor Arms. Heavy Duty Dual Arm Articulating TV Wall Mount for 32-70".

ultimovastgoed.nl

Home - Ultimo Vastgoed

Welkom bij Ultimo Vastgoed. Welkom bij Ultimo Vastgoed. Ultimo Vastgoed B.V. is een praktijk-expert op het gebied van herontwikkeling van bestaand vastgoed. Onze plannen blijven niet liggen op de tekentafel, maar worden daadwerkelijk gerealiseerd. Wij investeren voor eigen rekening en risico en staan ook open voor samenwerking met eigenaren van vastgoed met herontwikkelingspotentie. Aarzel niet om contact met ons op te nemen indien u projectkansen ziet. By sectors ›. Winkelcentrum, Doetinchem, Dennenweg.

ultimove.mobi

Ultimove.mobi

ultimove.net

Ultimove.net